American College of Rheumatology
@ACRheum
Global medical society providing education, research, advocacy, and practice management support to nearly 10,000 rheumatology professionals since 1934.
Registration for #ACR25 is open! Join us for time with your colleagues & the latest advancements/scientific breakthroughs in #rheum. Don’t delay—EARLY registration rates end August 21. Register → acr.tw/44pY0G8
What’s shaping the next chapter in #rheum? ACR Journals on Air features in-depth conversations on antiphospholipid syndrome, evolving workforce models, & innovative approaches to trial access & participation. Catch up HERE & subscribe TODAY → acr.tw/3PJPTyM

NOW OPEN: 2026 ILAR call for project proposals that advance #rheum in developing countries in the areas of patient/health professional education including population health and/or clinical practice & advocacy for #rheum. Deadline Sept. 15, 2025. Details → acr.tw/3DwTqug

👏 Join us in congratulating the 2024-5 graduating class of Rheum With a (re)View, a mentoring program dedicated to developing a strong pipeline of peer reviewers. 📖 See the graduates & learn more about the program → acr.tw/3xvknyR
👏 Join us in congratulating the 2024-5 graduating class of Rheum With a (re)View, a mentoring program dedicated to developing a strong pipeline of peer reviewers. 📖 See the graduates & learn more about the program → acr.tw/3xvknyR

Beat the clock! ⏰ Save when you register for #ACR25 BEFORE Aug. 21 & save even more by becoming a member. Plan your #rheum learning experience of the year by registering today → acr.tw/44pY0G8

New installment in the A&R Immunology for the Rheumatologist review series looks at systemic sclerosis–interstitial lung disease, the pathogenesis of SSc-ILD, autoantibodies in SSc-ILD, & role of B cells in the disease Tables 2-4 list autoantibody profiles, drugs used in…
NEW ISSUE ALERT! 🆕 The July 2025 issue of Arthritis & Rheumatology is now available → acr.tw/46UjBL4 @ACR_Journals

The ACR applauds @Humana’s pledge to cut 1/3 of outpatient prior auths by 2026 & speed up approvals. Next step? Include medications in these reforms to truly reduce burden for rheumatologists & improve access. #PriorAuth #Humana #ACR acr.tw/4m3p9as

🚨 Call for #ACR25 late-breaking abstracts opening soon! 🚨 Be ready to submit yours on July 31. Details → acr.tw/41sY6et

Does naming really matter in clinical practice? In this NEW episode, we explore how consistent terminology can improve care, research, & communication—especially for patients with autoimmune diseases. LISTEN NOW 🎧 → acr.tw/4kZPXaU @ACR_Journals

“CPPD is a bit of a headscratcher because it can mimic any number of other conditions,” says @BharatKumarMD, physician editor of The #Rheumatologist. “Luckily, new insights empower diagnosis & management so we can help manage this great mimic.” VIEW → acr.tw/3UoGoag

Don’t miss the next interactive session THIS WEEK in this complimentary series! Optimize and Improve Your Research Funding, July 25, 4:00 PM ET. FREE registration required. Details, facilitators, & registration → rheumatology.org/research-resou… #rheumresearch

Check out these new studies published this week in Arthritis & Rheumatology 👓 📖 🛋️ Adverse pregnancy outcomes among women with SSc in the Swedish Medical Birth Register doi.org/10.1002/art.43… Immunology series: Mechanisms of B Cell Tolerance in Health and Autoimmunity…
More great articles this week in Arthritis Care & Research! 🤩 Cost impact of switching patients with inflammatory arthritis to a biosimilar in BC, Canada doi.org/10.1002/acr.25… Review: race-based practices in pediatric rheumatology and alternatives to race-based practices…
In our newest episode, Dr. Dana DiRenzo answers a critical question: “With all the new therapies in development for Sjögren’s, how is the treatment landscape changing?” HER ANSWER → acr.tw/4mdDT6X
From the lab to the clinic—@jasonsknight discusses #APS research, treatment advances, & his personal journey in medicine on ACR Journals on Air. TUNE IN for a compelling conversation → acr.tw/3GxkWg8 @ACR_Journals

Updates from EULAR 2025, new FDA approval, & APEX Award wins—this week in The #Rheumatologist: Finding the Panacea acr.tw/4lC0ni0 FDA Approves Ustekinumab-stba for All Forms & Dosages as Its Reference Product acr.tw/4nWeLD6 B Original acr.tw/4kEVhjv…

In this episode of Rheum for Everyone, @BharatKumarMD, physician editor of The #Rheumatologist, talks about the fascinating & intriguing secret lives of #rheums—real life superheroes. 🦸 Watch → acr.tw/3UfOLVE
New installment in the Arthritis & Rheumatology Immunology for the Rheumatologist series reviews the underlying immunology and mechanisms of B cell tolerance and how these mechanisms inform our understanding of autoimmune pathogenesis
ACR/ARP MEMBER EXCLUSIVE—the NP/PA Rheumatology Curriculum, which gives a complete overview of how to integrate a NP or PA into a #rheum practice to improve patient outcomes, access, & care. 🔍 Explore → acr.tw/4hd0y0T
